Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for ICU-Acquired Weakness
NCT02523690Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorcaserin in muscle weakness, sponsored by Johns Hopkins University. Started Dec 2015; status: terminated.
02
Drugs
lorcaserin
03
Conditions
muscle weakness
Beyond the preview
Go deeper on NCT02523690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523690.